dc.contributor.author
Serna Gómez, Elena de la
dc.contributor.author
Montejo Egido, Laura
dc.contributor.author
Solé Cabezuelo, Brisa
dc.contributor.author
Castro Fornieles, Josefina
dc.contributor.author
Camprodon Boadas, Patricia
dc.contributor.author
Sugranyes, G.
dc.contributor.author
Rosa Justicia, Mireia
dc.contributor.author
Martínez-Arán, Anabel, 1971-
dc.contributor.author
Vieta i Pascual, Eduard, 1963-
dc.contributor.author
Vicent Gil, Muriel
dc.contributor.author
Serra Blasco, María
dc.contributor.author
Cardoner, N. (Narcís)
dc.contributor.author
Torrent Font, Carla
dc.date.issued
2025-03-31T16:39:29Z
dc.date.issued
2025-03-31T16:39:29Z
dc.date.issued
2021-02-22
dc.date.issued
2025-03-31T16:39:29Z
dc.identifier
https://hdl.handle.net/2445/220147
dc.description.abstract
Background: Offspring of patients diagnosed with bipolar disorder and schizophrenia (Off-BDSZ) have a high genetic risk of developing a mental illness. The aim of this project is to develop and investigate the efficacy of an intervention aimed at this population, based on the concept of cognitive reserve.
Methods: This is a multicenter randomized trial with an experimental test-retest design study with control group. Two groups will be included: a community comparison group (CC) and a Off-BDSZ group. A total of 108 Off-BDSZ and 65 CC aged between 6 and 25 years will be recruited. Off-BDSZ participants will be randomized to receive either Cognitive Reserve EnhAncement ThErapy (CREATE) (n=54), or a supportive approach (n=54). The CC group will be assessed at baseline. The duration of the intervention will be 3 months, with 12 weekly group sessions. The primary outcome will be the improvement in CR measured according to change in the Cognitive Reserve Assessment Scale in Health (CRASH) and Cognitive Reserve scale for Adolescents (CORE-A). All participants will be blindly evaluated using clinical, cognitive and neuroimaging measures at baseline, at three months (after the psychological intervention), and at twelve-month follow-up after treatment completion.
Discussion: The results will provide insight into whether the CREATE-Offspring version may enhance cognitive reserve (CR) in child, adolescent and young adult Off-BDSZ as well as advance knowledge about changes in clinical manifestations, neuropsychological performance and brain structure and function associated with improving CR. This novel and cost-effective intervention represents an advance in the framework of preventive interventions in mental health.
dc.format
application/pdf
dc.publisher
Elsevier España
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.rpsm.2021.02.003
dc.relation
Revista de Psiquiatria y Salud Mental, 2021, vol. 16, num.3, p. 184-191
dc.relation
https://doi.org/10.1016/j.rpsm.2021.02.003
dc.rights
cc-by-nc-nd (c) Sociedad Española de Psiquiatría y Sociedad Española de Psiquiatría Biológica, 2021
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Medicina)
dc.subject
Trastorn bipolar
dc.subject
Malalties mentals
dc.subject
Manic-depressive illness
dc.subject
Mental illness
dc.title
Effectiveness of enhancing cognitive reserve in children, adolescents and young adults at genetic risk for psychosis: study protocol for a randomized controlled trial
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion